Terminal cytoplasmic maturation of human megakaryocytes in vitro
- PMID: 3770100
Terminal cytoplasmic maturation of human megakaryocytes in vitro
Abstract
Several studies suggest that serum factors (thrombopoietins) regulate thrombopoiesis by altering the number, size, ploidy, and maturation rate of megakaryocytes (MK). Various in vivo systems have been used to quantitate these events. In this study, an in vitro system was developed to monitor terminal cytoplasmic maturation of isolated human MK. MK enriched by elutriation, which eliminated the MK progenitors, were suspended in culture with serum from either normal donors (NABS) or patients with aplastic anemia (AAS). In cultures composed of small platelet glycoprotein-positive mononuclear cells and morphologically immature MK, development was characterized by sequential shifts in MK through morphologically recognizable maturation stages I, II, III, and IV over eight days of incubation (I and II only; then I, II, III; II, III, IV; III and IV; then IV only). Platelet formation coincided with the appearances of stage IV cells. Cultures composed of a mixture of all stages followed a similar maturation sequence, only at an accelerated rate. AAS resulted in the more rapid appearances of the mature cells in either system. This study indicates that human MK can undergo terminal cytoplasmic maturation in vitro, and that altering culture conditions (AAS for NABS) can accelerate the rate of maturation. Three major events occur during megakaryocytopoiesis: proliferation of the progenitor cells, polyploidization, and cytoplasmic maturation. Now it is possible to study the terminal steps of differentiation independent of proliferative events.
Similar articles
-
Effects of thrombocytopoiesis-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes.Exp Hematol. 1989 Dec;17(11):1122-7. Exp Hematol. 1989. PMID: 2684680
-
Effects of megakaryocyte colony-stimulating factor on terminal cytoplasmic maturation of human megakaryocytes.Exp Hematol. 1987 Jul;15(6):657-63. Exp Hematol. 1987. PMID: 3595764
-
Serum from patients with various thrombopoietic disorders alters terminal cytoplasmic maturation of human megakaryocytes in vitro.Eur J Haematol. 1989 Mar;42(3):293-7. doi: 10.1111/j.1600-0609.1989.tb00115.x. Eur J Haematol. 1989. PMID: 2784391
-
Human megakaryocyte progenitor cells.Semin Hematol. 1998 Jul;35(3):183-91. Semin Hematol. 1998. PMID: 9685164 Review.
-
Hierarchical structure of human megakaryocyte progenitor cells.Stem Cells. 1996;14 Suppl 1:75-81. doi: 10.1002/stem.5530140709. Stem Cells. 1996. PMID: 11012205 Review.
Cited by
-
Thrombocytogenesis by megakaryocyte; Interpretation by protoplatelet hypothesis.Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(5):254-73. doi: 10.2183/pjab.87.254. Proc Jpn Acad Ser B Phys Biol Sci. 2011. PMID: 21558761 Free PMC article. Review.
-
Platelet production by megakaryocytes: protoplatelet theory justifies cytoplasmic fragmentation model.Int J Hematol. 2008 Oct;88(3):255-267. doi: 10.1007/s12185-008-0147-7. Epub 2008 Aug 28. Int J Hematol. 2008. PMID: 18751873 Review.
-
In vivo platelet production from mature megakaryocytes: does platelet release occur via proplatelets?Int J Hematol. 2005 Apr;81(3):208-19. doi: 10.1532/IJH97.04177. Int J Hematol. 2005. PMID: 15814332 Review.
-
Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia.J Clin Invest. 1995 Jun;95(6):2973-8. doi: 10.1172/JCI118005. J Clin Invest. 1995. PMID: 7539462 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources